USF3
Basic information
Region (hg38): 3:113648385-113696646
Previous symbols: [ "KIAA2018" ]
Links
Phenotypes
GenCC
Source:
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
- Cowden disease (Supportive), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USF3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 94 | 102 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 94 | 11 | 2 |
Variants in USF3
This is a list of pathogenic ClinVar variants found in the USF3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-113651163-G-T | Benign (Jul 15, 2020) | |||
3-113655042-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
3-113655044-A-G | not specified | Uncertain significance (Sep 27, 2021) | ||
3-113655157-C-A | not specified | Uncertain significance (Dec 19, 2022) | ||
3-113655282-T-C | not specified | Uncertain significance (Apr 18, 2023) | ||
3-113655292-A-C | not specified | Uncertain significance (Dec 28, 2022) | ||
3-113655324-T-C | not specified | Uncertain significance (Sep 06, 2022) | ||
3-113655356-G-A | not specified | Uncertain significance (Feb 03, 2022) | ||
3-113655503-G-A | not specified | Uncertain significance (Jan 05, 2022) | ||
3-113655527-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
3-113655562-G-T | not specified | Uncertain significance (May 09, 2022) | ||
3-113655566-C-G | not specified | Uncertain significance (Feb 27, 2024) | ||
3-113655581-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
3-113655584-T-C | not specified | Uncertain significance (Nov 06, 2023) | ||
3-113655606-G-A | not specified | Uncertain significance (Apr 08, 2023) | ||
3-113655612-G-A | not specified | Uncertain significance (Aug 15, 2024) | ||
3-113655632-G-C | not specified | Uncertain significance (Aug 15, 2024) | ||
3-113655636-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
3-113655638-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
3-113655710-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
3-113655732-C-G | not specified | Uncertain significance (Jun 10, 2024) | ||
3-113655770-T-C | not specified | Uncertain significance (Sep 03, 2024) | ||
3-113655780-G-A | not specified | Conflicting classifications of pathogenicity (Dec 01, 2022) | ||
3-113655920-T-C | not specified | Uncertain significance (Dec 05, 2022) | ||
3-113655941-T-C | not specified | Uncertain significance (Oct 24, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
USF3 | protein_coding | protein_coding | ENST00000316407 | 5 | 48262 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000101 | 124840 | 0 | 18 | 124858 | 0.0000721 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.793 | 1063 | 1.14e+3 | 0.934 | 0.0000563 | 14752 |
Missense in Polyphen | 342 | 411.47 | 0.83117 | 5338 | ||
Synonymous | 0.784 | 391 | 411 | 0.951 | 0.0000205 | 4573 |
Loss of Function | 6.94 | 7 | 69.3 | 0.101 | 0.00000371 | 851 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000248 | 0.000247 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000556 | 0.0000555 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000109 | 0.0000971 |
Middle Eastern | 0.0000556 | 0.0000555 |
South Asian | 0.0000752 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the negative regulation of epithelial- mesenchymal transition, the process by which epithelial cells lose their polarity and adhesion properties to become mesenchymal cells with enhanced migration and invasive properties. {ECO:0000269|PubMed:28011713}.;
Intolerance Scores
- loftool
- rvis_EVS
- -0.71
- rvis_percentile_EVS
- 14.5
Haploinsufficiency Scores
- pHI
- 0.423
- hipred
- Y
- hipred_score
- 0.518
- ghis
- 0.541
Mouse Genome Informatics
- Gene name
- Usf3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;negative regulation of epithelial to mesenchymal transition
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein dimerization activity